Treatment Sequencing in HER2+ mBC

 

Memorial Sloan Kettering Cancer Center
N

HER2- Directed Targeted Agents for Brain Metastasis in Metastatic Breast Cancer

By Memorial Sloan Kettering Cancer Center FEATURING Neil Iyengar
By Memorial Sloan Kettering Cancer Center FEATURING Neil Iyengar
653 views
March 15, 2022
0 Comments
Login to view comments. Click here to Login
Treatment Sequencing in HER2+ mBC
31:50
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2022

New Approaches in the Management of HER2+ Breast Cancers

Feat. S. Hurvitz
20:08
Memorial Sloan Kettering Cancer Center

HER2- Directed Targeted Agents for Brain Metastasis in Metastatic Br…

Feat. N. Iyengar
25:57
V.K. Gadi

2022 Updates in HER2+ mBC

14:00
Mridula George

Treatment Options in HER2+ Breast Cancer

07:02
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 Updated Results of Tucatinib vs. Placebo Added to Trastuz…

Feat. N. Lin
09:07
SABCS 2021 Conference Coverage on VuMedi

SABCS 2021 on MRI Screening vs. SYMptom-Directed Surveillance for Br…

Feat. K. Jerzak
21:23
Stanford Medicine

Brain Metastases Are Now More Treatable in HER2+ Metastatic Breast C…

Feat. M. Pegram
14:14
Naomi Dempsey

Recognizing Common Symptoms in HER2+ Metastatic Breast Cancer

22:51
NYU Langone

Case Presentation on HER2+ Breast Cancer: Adapting Patient Care to a…

Feat. D. Marks